Zevra Therapeutics GAAP EPS of -$0.06 beats by $0.13, revenue of $20.4M beats by $3.44M

1 month ago 2

Earnings News

Zevra Therapeutics, Inc. press release (NASDAQ:ZVRA): Q1 GAAP EPS of -$0.06 beats by $0.13.
Revenue of $20.4M (+494.8% Y/Y) beats by $3.44M.
Cash, cash equivalents and investments were $68.7 million as of Mar. 31, 2025. Combined with the net proceeds of $148.3 million from the sale

Recommended For You

More Trending News

Read Entire Article